Skip to main content
Premium Trial:

Request an Annual Quote

NIEHS Awards Caliper Knockout Mouse Model Contract Worth Up To $7M

NEW YORK (GenomeWeb News) - Caliper Life Sciences said today that it has received a contract from the National Institutes of Environmental Health Services valued at up to $7 million to develop customized transgenic and knockout mouse models though its Xenogen Biosciences business.
 
The company said the contract will begin immediately and could run up to 10 years “at the option of NIEHS.” The contract was awarded to Caliper through a competitive bid process.
 
Caliper said the NIEHS will use the genetically modified mouse models as part of its research to identify and possibly prevent hazardous conditions and exposure in humans.
 
Caliper said it has made over 9,000 unique mouse and rat models, some of which have already been supplied to the NIEHS through a previous multi-year agreement.
 
Xenogen is the in vivo pharmaceutical drug-discovery branch of Caliper Discovery Alliances & Services.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.